Search Results 211-220 of 17289 for Cyclophosphamide

  1. Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer - Mayo Clinic

    ... cyclophosphamide or cyclophosphamide-methotrexate-5-fluorouracil) as opposed to simplified oral regimens (capecitabine). In this trial, both the risk of ...

  2. Lisocabtagene maraleucel (intravenous route) - Side effects & uses - Mayo Clinic

    It is given 2 to 7 days after completing treatment with other cancer medicines (eg, fludarabine, cyclophosphamide). You may also receive other medicines (eg ...

  3. Kidney Tumor Clinical Trials - Mayo Clinic Research

    Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo ( ...

  4. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

    ... cyclophosphamide 1 g/m^2, oral 6-mercaptopurine, or oral methotrexate (other low dose chemotherapy may be allowable, however any other options not listed ...

  5. Obecabtagene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    It is given 2 or 4 days after completing treatment with other cancer medicines (eg, fludarabine, cyclophosphamide). This medicine should come with a ...

  6. Ciltacabtagene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    It is given 2 to 4 days after completing treatment with other cancer medicines (eg, fludarabine, cyclophosphamide). You may also receive other medicines (eg ...

  7. Brexucabtagene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    It is given 3 days after completing treatment with other cancer medicines (eg, fludarabine, cyclophosphamide). Your doctor will check you for unwanted ...

  8. Study to Analyze Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

    Scheduled to receive intravenous HEC (Highly Emetogenic Chemotherapy) (either cisplatin-containing regimen or doxorubicin and cyclophosphamide [AC]).

  9. CAR-T Cell Therapy Clinical Trials - Mayo Clinic Research

    Quercetin is a compound found in plants that may prevent multiple myeloma from forming. Chemotherapy such as cyclophosphamide ... A Study Of CC-97540 (BMS- ...

  10. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

    ... cyclophosphamide, doxorubicin, vincristine and prednisone/prednisolone [R-CHOP]) is effective and safe, compared with placebo in combination with standard ...